C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation

Two consecutive multi-center phase II trials were designed to prove the hypothesis, whether therapeutic modeling of tumor-associated infl ammatory processes could result in improved tumor response. Therapy in both trials consisted of low-dose capecitabine 1g/m2 twice daily p.o. for 14 days, every 3...

Descripció completa

Dades bibliogràfiques

Autors principals:	Albrecht Reichle, Jochen Grassinger, Klaus Bross, Jochen Wilke, Thomas Suedhoff, Bernhard Walter, Wolf-Ferdinand Wieland, Anna Berand, Reinhard Andreesen
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2006-01-01
Col·lecció:	Biomarker Insights
Matèries:	Anti-inflammatory therapy Interferon-alpha PPARgamma COX-2
Accés en línia:	http://la-press.com/article.php?article_id=25
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!